Browse by category

Ascletis' announces promising results for ASC47 adipose-targeted THRβ

Ascletis Pharma has announced that results of its Phase I single ascending dose (SAD) study in Australia in subjects with elevated...

Survey finds 50% of post-bariatric surgery patients feel less stress during the holidays

1 hour ago

Journal Watch 18/12/2024

4 hours ago

True You Weight Loss to initiate two clinical trials assessing gastric fundal mucosal ablation

5 hours ago

Weekly Digest